Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.

Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R J Clin Oncol. 2007 May 20,25(15):2012-8.

PKC delta is involved in signal attenuation in CD3+ T cells.

Gruber T, Barsig J, Pfeifhofer C, Ghaffari-Tabrizi N, Tinhofer I, Leitges M, Baier G. Immunology Letters. 2005 Jan 31,96(2): 291-3.

Polyacetylenes from the Apiaceae vegetables carrot, celery fennel parsley and parsnip and their cytotoxic activities.

Zidorn C, Jöhrer K, Ganzera M, Schubert B, Sigmund EM, Mader J, Greil R, Ellmerer EP, Stuppner H. J Agric Food Chem. 2005 Apr 6,53(7):2518-23.

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients.

Fey MF, Greil R, Jost LM Ann Oncol. 2005,16 Suppl 1:i48-9. No abstract available.

Purine antagonists for chronic lymphocytic leukemia: Results of a comprehensive meta-analysis

Steurer, M, Pall, G, Richards, S, Schwarzer, G, Bohlius, J, Greil, R ANN ONCOL. 2005, 16: 203-204.

Alemtuzumab is effective in patients with advanced, pretreated B-cell chronic lymphocytic leukemia: A nationwide study of routine use in Austria

Fiegl, M, Falkner, A, Hopfinger, G, Brugger, S, Zabernigg, A, Haslbauer, F, Andel, J, Thaler, J, Fridrik, M, Bauer, F, Mian, M, Tatzreiter, G, Zoier, N, Demirtas, D, Postner, G, Auberger, J, Gastl, G, Greil, R BLOOD. 2005, 106(11): 833A-833A.

Chemotherapie im Alter

Greil, R, Faber, V, In: Likar, R, Bernatzky, G, Pipam, W, Janig, H, Sadjak, A, editors(s). Lebensqualität im Alter. Springer, p. 57-264. (ISBN: 978-3-211-21197-7)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma.

Harrouseau JL, Greil R, Kloke O Ann Oncol. 2005,16 Suppl 1:i48-9. No abstract available.

ESMO recommendations for the application of hematopoietic growth factors.

Greil R, Jost LM Ann Oncol. 2005,16 Suppl 1:i80-2. No abstract available.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia.

Hallek M, Stahel RA, Greil R Ann Oncol. 2005,16 Suppl 1:i50-1. No abstract available.